Did The Collapse Of Optobionics Lead To The Future Of Artificial Vision?

Authored by Karla Rossouw

In medical technology, the collapse of a company doesn’t always mean the death of its scientific discoveries, and Optobionics is a true example of this statement.

Imagine a microchip, thinner than a strand of hair, acting like a tiny solar panel inside a human eye. Well, before shutting down in 2007, Optobionics actually built this microchip, tested it and proved the body could tolerate it for years after implanting it.

So, what happened to this incredible science when the business collapsed? The end of the company was just the beginning of new technology and the project left behind incredible insights into what the next generation of researchers needed to fix to make artificial vision a reality. It also led to an accidental discovery about healing cells that researchers didn’t expect.

How Optobionics Created the Blueprint for Today’s Wireless Implants

While many researchers focused on implants placed on top of the retina, Optobionics took a different approach by placing its chip underneath it. Competitors used older, top-mounted devices that required external cameras, implanted electronics and wired connections running directly into the eye. This type of bulky hardware introduced more points of failure and surgical complications than anything else. That’s why Optobionics wanted a cleaner approach and aimed to take over the job of the eye’s damaged light-sensing cells from the ground up.

Optobionics’ Artificial Silicon Retina microchip contained around 5,000 microscopic solar cells and was designed to convert light energy into electrical impulses. The company managed to prove that a miniature device could stay beneath the human retina for years, without being rejected, getting infected or showing the slightest movement. Unfortunately, the passive chip couldn’t generate enough power from ordinary light to create clear, useful artificial vision.

Luckily, it didn’t stop there, as modern vision technology has built upon Optobionic’s idea while fixing its primary flaw. Today’s PRIMA System revisits the same broad wireless, photovoltaic subretinal concept, while it solves the power limitation of the original chip by using augmented-reality glasses.

The glasses capture and process the scene before projecting it onto the chip using pulsed infrared light. Essentially, this gives the implant both the power and visual information it needs to function properly, and researchers can now focus on placing more pixels into the chips to improve visual clarity.

What Was the Accidental Breakthrough of Neuroprotection?

During the clinical trials for the microchip, researchers noticed patients were reporting improved visual function not just in the specific area where the chip was placed, but in areas of the eye far away from the implant. Some patients even noted better colour perception and contrast across their wider field of vision.

It didn’t make logical sense at the time, but Optobionics generated an unexpected neuroprotection hypothesis that was later supported by animal studies. It was discovered that mild electrical stimulation caused by the microchip triggered the release of protective proteins that may have helped damaged retinal cells survive and function better.

Does This Discovery Mean That Electricity Can Protect Our Remaining Sight?

While it isn’t yet an established, proven treatment for the general public, this accidental discovery changed how scientists think about treating degenerative eye diseases.

As a result, low-level electrical stimulation is now being researched as a protective therapy, completely independent of restoring sight through a camera. Additionally, researchers are looking into how these tiny electrical pulses might delay the progression of blindness in retinal eye conditions like retinitis pigmentosa.

Scientists Attempt to Bypass the Eye Entirely If It Is Too Damaged

Because retinal diseases can completely destroy the eye’s infrastructure, scientists realised that relying on the eye itself might not always be a viable option. In terms of treating total blindness, a degraded optic nerve simply can’t carry a signal from the eye to the brain. Think of the optic nerve like a broken bridge; no matter how fast the car is, it cannot cross to the other side.

This forced scientists to seek a different approach that would allow them to restore sight through a method that skips the damaged eye completely. One of these approaches focused on brain implants, such as the Orion device. If the eye or optic nerve is too damaged to work, these systems bypass the eye completely and use a tiny camera on a pair of glasses to send visual signals straight to an implant in the part of the brain that processes sight.

Restoring Sight Without Using Microchips?

Putting electronic hardware inside the human body comes with several risks, which could result in anything from replacing certain devices to patients needing eye surgery. Because of this, many doctors and patients are cautious about relying entirely on physical implants. Scientists are now exploring a biological alternative that leaves silicon microchips out of the eye altogether.

This field is called optogenetics. Instead of implanting a piece of hardware, scientists use gene therapy to teach the eye’s surviving cells to produce their own light-sensitive proteins. In simple terms, the treatment reprograms healthy cells that don’t normally detect light, turning them into natural biological light sensors.

Once these proteins are active, the cells can react to light on their own and send visual signals straight down the optic nerve to the brain. Because there’s no electronic chip sitting inside the eye, there are fewer internal parts to break down or wear out. For this reason, many view it as a much more sustainable path forward, but technology still plays a supporting role, as patients often wear specialised goggles to project amplified light pulses onto these newly reprogrammed cells.

Was Optobionics a Failed Attempt?

The closure of Optobionics wasn’t a dead end for artificial vision but actually the entry point the medical field needed. It proved that the human eye could tolerate foreign microchips, it revealed the hidden healing potential of neuroprotection, and it gave researchers the precise data they needed to build the next generation of visual prosthetics.

Optobionics did not fail. It managed to successfully create the instruction manual for researchers to understand the future of human sight.